142 related articles for article (PubMed ID: 34411399)
21. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
[TBL] [Abstract][Full Text] [Related]
22. Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study.
Kamada Y; Hida K; Ishibashi H; Sako S; Mizumoto A; Ichinose M; Padmanabhan N; Yoshida S; Yonemura Y
World J Surg Oncol; 2021 Jan; 19(1):31. PubMed ID: 33509224
[TBL] [Abstract][Full Text] [Related]
23. [The Significance and Limitations of Curative Resection for Peritoneal Metastases of Colorectal Cancer].
Yokomizo H; Yoshimatsu K; Yano Y; Okayama S; Sakuma A; Satake M; Yamada Y; Matsumoto A; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Kato H; Naritaka Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1446-1448. PubMed ID: 28133018
[TBL] [Abstract][Full Text] [Related]
24. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
Le VH; Thornblade L; Ituarte PHG; Lai LL; Melstrom KA
J Surg Oncol; 2021 Feb; 123(2):622-629. PubMed ID: 33616972
[TBL] [Abstract][Full Text] [Related]
25. The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study.
van de Vlasakker VCJ; van Erning FN; Lurvink RJ; de Hingh IHJT; Nienhuijs SW
World J Surg Oncol; 2023 Oct; 21(1):328. PubMed ID: 37845754
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Synchronous Peritoneal Metastases in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Zhang Y; Qin X; Luo R; Wang H; Wang H; Luo H
Front Oncol; 2022; 12():885504. PubMed ID: 35795042
[TBL] [Abstract][Full Text] [Related]
27. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
Rovers KP; Bakkers C; Simkens GAAM; Burger JWA; Nienhuijs SW; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; Ayez N; de Boer NL; van Meerten E; Tuynman JB; Kusters M; Sluiter NR; Verheul HMW; van der Vliet HJ; Wiezer MJ; Boerma D; Wassenaar ECE; Los M; Hunting CB; Aalbers AGJ; Kok NFM; Kuhlmann KFD; Boot H; Chalabi M; Kruijff S; Been LB; van Ginkel RJ; de Groot DJA; Fehrmann RSN; de Wilt JHW; Bremers AJA; de Reuver PR; Radema SA; Herbschleb KH; van Grevenstein WMU; Witkamp AJ; Koopman M; Haj Mohammad N; van Duyn EB; Mastboom WJB; Mekenkamp LJM; Nederend J; Lahaye MJ; Snaebjornsson P; Verhoef C; van Laarhoven HWM; Zwinderman AH; Bouma JM; Kranenburg O; van 't Erve I; Fijneman RJA; Dijkgraaf MGW; Hemmer PHJ; Punt CJA; Tanis PJ; de Hingh IHJT; ;
BMC Cancer; 2019 Apr; 19(1):390. PubMed ID: 31023318
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
29. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
Ripley RT; Davis JL; Kemp CD; Steinberg SM; Toomey MA; Avital I
Trials; 2010 May; 11():62. PubMed ID: 20500867
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience.
Zhou R; Liu Y; Wang Y; Huo X; Zhu J; Zhang T
Int J Clin Oncol; 2020 Oct; 25(10):1822-1829. PubMed ID: 32591962
[TBL] [Abstract][Full Text] [Related]
31. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
[TBL] [Abstract][Full Text] [Related]
32. [Survival rates of patients with mucinous adenocarcinoma of the colorectum].
Maksimović S
Med Arh; 2007; 61(1):26-9. PubMed ID: 17582971
[TBL] [Abstract][Full Text] [Related]
33. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
[TBL] [Abstract][Full Text] [Related]
34. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
[TBL] [Abstract][Full Text] [Related]
35. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Goéré D; Glehen O; Quenet F; Guilloit JM; Bereder JM; Lorimier G; Thibaudeau E; Ghouti L; Pinto A; Tuech JJ; Kianmanesh R; Carretier M; Marchal F; Arvieux C; Brigand C; Meeus P; Rat P; Durand-Fontanier S; Mariani P; Lakkis Z; Loi V; Pirro N; Sabbagh C; Texier M; Elias D;
Lancet Oncol; 2020 Sep; 21(9):1147-1154. PubMed ID: 32717180
[TBL] [Abstract][Full Text] [Related]
36. Carcinoembryonic antigen and matrix metalloproteinase 2 serum and peritoneal washes concentration in staging and prognosis in colorectal cancer patients.
Guzel T; Mirowska-Guzel D; Lech G; Wroński M; Iwanowska M; Słodkowski M
Pol Przegl Chir; 2018 Jun; 90(5):36-43. PubMed ID: 30426942
[TBL] [Abstract][Full Text] [Related]
37. High risk features of primary colorectal carcinomas which subsequently undergo peritonectomy.
Leung V; Huang N; Liauw W; Morris DL
Eur J Surg Oncol; 2016 Jun; 42(6):836-40. PubMed ID: 26995114
[TBL] [Abstract][Full Text] [Related]
38. Prevention of peritoneal recurrence in high-risk colorectal cancer and evidence of T4 status as a potential risk factor.
Kyang LS; Valle SJ; Alzahrani NA; Morris DL
ANZ J Surg; 2018 Oct; 88(10):975-981. PubMed ID: 29510456
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis.
Sato H; Maeda K; Kotake K; Sugihara K; Takahashi H
J Gastroenterol; 2016 May; 51(5):465-72. PubMed ID: 26377391
[TBL] [Abstract][Full Text] [Related]
40. Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG.
Taibi A; Lo Dico R; Kaci R; Naneix AL; Mathonnet M; Pocard M
Surg Oncol; 2020 Jun; 33():158-163. PubMed ID: 32561082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
